The polyglutamine-expanded protein ataxin-3 decreases bcl-2 mRNA stability

Biochemical and Biophysical Research Communications

Volumn 365, Issue 2, 2008, Pages 232-238

  Tien, Chih Liang ^a   Wen, Feng Chen ^a   Hsieh, Mingli ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Bcl 2; mRNA stability; Polyglutamine expanded ataxin 3; Spinocerebellar ataxia type 3

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ADENOSINE DERIVATIVE; ATAXIN 3; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; POLYGLUTAMINE; PROTEIN BCL 2;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; DEGRADATION; GENETIC STABILITY; GENETIC TRANSFECTION; MACHADO JOSEPH DISEASE; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; GENES, BCL-2; NUCLEAR PROTEINS; PEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; RNA STABILITY; TRANSCRIPTION FACTORS;

EID: 36248946819     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.162     Document Type: Article

References (33)

1. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., Kawakami H., Nakamura S., Nishimura M., and Akiguchi I. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8 (1994) 221-227
2. Scheel H., Tomiuk S., and Hofmann K. Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Hum. Mol. Genet. 12 (2003) 2845-2852
3. Burnett B., Li F., and Pittman R.N. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet. 12 (2003) 3195-3205
4. Berke S.J., Chai Y., Marrs G.L., Wen H., and Paulson H.L. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J. Biol. Chem. 280 (2005) 32026-32034
5. Burnett B.G., and Pittman R.N. The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc. Natl. Acad. Sci. USA 102 (2005) 4330-4335
6. Heir R., Ablasou C., Dumontier E., Elliott M., Fagotto-Kaufmann C., and Bedford F.K. The UBL domain of PLIC-1 regulates aggresome formation. EMBO Rep. 7 (2006) 1252-1258
7. Warrick J.M., Morabito L.M., Bilen J., Gordesky-Gold B., Faust L.Z., Paulson H.L., and Bonini N.M. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell 18 (2005) 37-48
8. Tsai H.F., Tsai H.J., and Hsieh M. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells. Biochem. Biophys. Res. Commun. 324 (2004) 1274-1282
9. Li F., Macfarian T., Pittman R.N., and Chakravarti D. Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J. Biol. Chem. 277 (2002) 45004-45012
10. Evert B.O., Vogt I.R., Vieira-Saecker A.M., Ozimek L., de Vos R.A., Klockgether E.R.T., and Wullner U. Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J. Neuropathol. Exp. Neurol. 62 (2003) 1006-1018
11. Evert B.O., Araujo J., Vieira-Saecker A.M., de Vos R.A., Harendza S., Klockgether T., and Wullner U. Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J. Neurosci. 26 (2006) 11474-11486
12. Wen F.C., Li Y.H., Tsai H.F., Lin C.H., Li C., Liu C.S., Lii C.K., Nukina N., and Hsieh M. Down-regulation of heat shock protein 27 in neuronal cells and non-neuronal cells expressing mutant ataxin-3. FEBS Lett. 546 (2003) 307-314
13. Chang W.H., Cemal C.K., Hsu Y.H., Kuo C.L., Nukina N., Chang M.H., Hu H.T., Li C., and Hsieh M. Dynamic expression of Hsp27 in the presence of mutant ataxin-3. Biochem. Biophys. Res. Commun. 336 (2005) 258-267
14. Mauri P.L., Riva M., Ambu D., De Palma A., Secundo F., Benazzi L., Valtorta M., Torrora P., and Fusi P. Ataxin-3 is subjected to autolytic cleavage. FEBS J. 273 (2006) 4277-4286
15. Yamada M., Tsuji S., and Takahashi H. Pathology of CAG repeat diseases. Neuropathology 20 (2000) 319-325
16. Tobin A.J., and Signer E.R. Huntington's disease: the challenge for cell biologists. Trends Cell Biol. 10 (2000) 531-536
17. Yamada M., Shimohata M., Sato T., Tsuji S., and Takahashi H. Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy. Neuropathology 26 (2006) 346-351
18. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
19. Garcia I., Martinou I., Tsujimoto Y., and Martinou J.C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258 (1992) 302-304
20. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., and Pietra C. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13 (1994) 1017-1030
21. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Nakayama K., Negishi I., Senju S., Zhang Q., and Fujii S. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267 (1995) 1506-1510
22. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
23. Liu Y.Z., Boxer L.M., and Latchman D.S. Activation of the bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic Acids Res. 27 (1999) 2086-2090
24. Smith M.D., Ensor E.A., Coffin R.S., Boxer L.M., and Latchman D.S. Bcl-2 transcription from the proximal p2 promoter is activated in neuronal cells by Brn-3a POU family transcription factor. J. Biol. Chem. 273 (1998) 16715-16722
25. Chodosh L.A., Fire A., Samuels M., and Sharp P.A. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264 (1989) 2250-2257
26. Jacobson A., and Peltz S.W. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu. Rev. Biochem. 65 (1996) 693-739
27. Sengupta T.K., Bandyopadhyay S., Fernandes D.J., and Spicer E.K. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J. Biol. Chem. 12 (2004) 10855-10863
28. Lapucci A., Donnini M., Papucci L., Witort E., Tempestini A., Bevilacqua A., Nicolin A., Brewer G., Schiavone N., and Capaccioli S. AUF1 is a bcl-2 A+U-rich element-binding protein involved in bcl-2 mRNA destabilization during apoptosis. J. Biol. Chem. 277 (2002) 16139-16146
29. Reed J.C. Mechanisms of apoptosis avoidance in cancer. Curr. Opin. Oncol. 11 (1999) 68-75
30. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3 (1997) 614-620
31. Tsujimoto Y., and Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett. 466 (2000) 6-10
32. Suzuki A., Matsuzawa A., and Iguchi T. Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene 13 (1996) 31-37
33. Yoshizawa T., Yamagishi Y., Koseki N., Goto J., Yoshida H., Shibasaki F., Shoji S., and Kanazawa I. Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch. Hum. Mol. Genet. 9 (2000) 69-78